Insomnia subtypes and sleep meds: CBT-I and trazodone for adults with high blood pressure
Official title: 1/2 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial
Funded at Pennsylvania State Univ Hershey Med Ctr · NIH-11418414 · Data updated 2026-11-12
We’re testing whether a sleep therapy (CBT-I) and the antidepressant trazodone help adults with insomnia and high blood pressure, especially those with the short-sleep-insomnia subtype.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State Univ Hershey Med Ctr NIH-funded |
| Lab location | 1 site (Hershey, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $1,415,302 |
| NIH project number | 5UH3HL161342-04 |
| Project ID | NIH-11418414 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults 21+ with insomnia and elevated blood pressure, including those characterized as insomnia with short sleep duration.
✕Less likely to help
Participants without insomnia or without elevated blood pressure may not benefit.
What this research studies
This project will enroll adults with insomnia and elevated blood pressure to see if CBT-I works differently for those who sleep short vs. normal duration. After a 4-site observational phase, participants who do not fully respond to CBT-I may be randomized to trazodone or placebo to see if the medication helps sleep and lowers blood pressure. The study builds on prior findings showing ISS may respond differently to CBT-I and trazodone, with potential effects on sleep time, blood pressure, and cortisol. If successful, the approach could personalize insomnia treatment for people at cardiovascular risk.
Why it matters
Potential benefit: If successful, patients could receive a more effective, tailored treatment plan for insomnia that also helps manage blood pressure.
How similar studies have gone: Preliminary data suggest differential responses to CBT-I and trazodone in different insomnia phenotypes, supporting further testing.
Where this research is happening
-
Pennsylvania State Univ Hershey Med Ctr
Hershey, United States Active
Researchers
- Principal investigator: Vgontzas, Alexandros N — Pennsylvania State Univ Hershey Med Ctr
- Study coordinator: Vgontzas, Alexandros N
Related research
Other NIH-funded projects on the same topics.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Cognitive-Behavioral Therapy and Trazodone for Sleep and Blood Pressure in Insomnia Subtypes
This program tests how CBT-I and trazodone help sleep and blood pressure in adults with insomnia, focusing on those with short sleep duration versus normal sleep duration.
-
Sleep therapy versus trazodone for short-sleep insomnia and high blood pressure
This project compares a talk-based sleep program (CBT-I) and the medication trazodone to help adults with insomnia who also have elevated blood pressure, especially those who sleep less at night.
-
Behavioral therapy and trazodone for insomnia types that affect sleep time and blood pressure
This research will compare cognitive behavioral therapy and the medication trazodone to help adults with insomnia and high blood pressure sleep more and lower their blood pressure.
-
Cognitive behavioral therapy and trazodone for insomnia-related short sleep and high blood pressure
This project compares talk-based sleep therapy and the medication trazodone to help adults with insomnia sleep longer and lower their blood pressure, especially if they sleep less than usual.
-
Effects of therapy and medication on sleep and blood pressure in people with insomnia
This study is looking at how two different treatments—Cognitive Behavioral Therapy for Insomnia (CBT-I) and the medication trazodone—can help improve sleep quality and lower blood pressure in adults who struggle with insomnia, especially those who don’t get enough sleep.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.